Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis
BACKGROUND: Antiviral medications are being given empirically to some patients with
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …
Old and re-purposed drugs for the treatment of COVID-19
SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
CTR Vegivinti, KW Evanson, H Lyons, I Akosman… - BMC Infectious …, 2022 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …
threat to public health worldwide. The purpose of this study was to review current evidence …
Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019
A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
Resolution of coronavirus disease 2019 (COVID-19)
K Habas, C Nganwuchu, F Shahzad… - Expert review of anti …, 2020 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) was first detected in China
in December, 2019, and declared as a pandemic by the World Health Organization (WHO) …
in December, 2019, and declared as a pandemic by the World Health Organization (WHO) …
SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review
JAC Nascimento Junior, AM Santos… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Coronavirus has been responsible for several virus outbreaks since 2003,
caused by SARS-CoV-1, MERS-CoV, and currently SARS-CoV-2 (COVID-19), the causative …
caused by SARS-CoV-1, MERS-CoV, and currently SARS-CoV-2 (COVID-19), the causative …
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
The latest pandemic, coronavirus disease-2019 (COVID-19), is associated with high
prevalence and easy transmission, which is expanding globally with no conventional …
prevalence and easy transmission, which is expanding globally with no conventional …
[HTML][HTML] Medical management of COVID-19: evidence and experience
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
[HTML][HTML] SARS‐CoV‐2 virus infection: targets and antiviral pharmacological strategies
DM de Oliveira Campos, UL Fulco… - Journal of evidence …, 2020 - ncbi.nlm.nih.gov
The current pandemic of coronavirus disease 2019 (COVID-19) poses a threat to global
public health owing to its high rate of spread and its association with severe forms of …
public health owing to its high rate of spread and its association with severe forms of …
Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …